Archives multiple-sclerosis

by in
Entry Author Date Location
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
23andMe Pharma? That’s the Plan, Says the Genetic Test Maker 03/12/15 San Francisco
RayVio Absorbs $9.3M for UV Technology to Clean Water and Air 03/10/15 San Francisco
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Roundup: UT’s Food Lab, Houston Angel Network, SecureNok, & More 02/18/15 Texas
East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More 02/13/15 Boston
Fannin Spinout Acelerox Aims to Halt Immune Attacks With Nanotech 02/11/15 Texas
With Early Data, Alkermes Plots Quick Jump to Pivotal Study For MS Drug 02/09/15 Boston
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
West Coast Biotech Roundup: Qualcomm, Google X, Mapp, Onyx, & More 01/29/15 San Francisco
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
Speaking LINGO, Biogen R&D Chief Wants to Push Nerve Repair Boundary 01/26/15 Boston
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M 12/18/14 Boston
Deltanoid and Beyond: Madison Legend DeLuca Has More “D” To Play 11/17/14 Wisconsin
Alkermes Spinoff Civitas, Poised for IPO, Sells to Acorda for $525M 09/24/14 Boston
East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More 09/15/14 Boston
To Fight Cramps, Christoph Westphal Taps Boston All-Stars for $40M 09/09/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Tapping UCSF Invention, Roche and Versant Dive Into Myelin Repair 06/23/14 San Francisco
RNA Therapeutics Are Here to Stay 06/05/14 San Diego
A Few Raindrops Amid Texas Biotech IPO Drought 05/30/14 Texas
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
San Diego Life Sciences Roundup: Isis, Receptos, Suneva, and More 01/17/14 San Diego
San Diego Life Sciences Roundup: Receptos, Auspex, Avelas, and More 01/10/14 San Diego
Page 1 of 7 next page »